EYE-103 is under clinical development by Eyebiotech and currently in Phase III for Diabetic Macular Edema. According to GlobalData, Phase III drugs for Diabetic Macular Edema have a 62% phase ...
Retrobulbar hemorrhage is an uncommon, vision-threatening complication of orbit and eyelid surgery. We review the incidence of retrobulbar hemorrhage, risk factors, orbital anatomy ...
Data from phase 3 trials of the drug in diabetic macular oedema (DMO ... when it came to inflammatory reactions in the eye. Earlier this year, Novartis halted three trials of Beovu in wet age ...
13, 2024 — New research highlights the possibility of screening people with type 2 diabetes for liver damage at the same time as they undergo screening for eye ... Groundbreaking Antidiabetic ...
The aim of this study was to investigate if type II diabetic patients have higher risk of developing peptic ulcer bleeding (PUB) and to identify possible risk factors of PUB in diabetic patients.
Opens in a new tab or window Abbreviated antiplatelet therapy may be as effective as the standard duration in preventing major adverse cardiac events in patients with diabetes and high bleeding ...